Inactive

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0001 for an unrestrictive procurement for Buprenorphine HCL/Naloxone HCL Sublingual Ta... PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0001 for an unrestrictive procurement for Buprenorphine HCL/Naloxone HCL Sublingual Tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79721R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 27, 2020, with a tentative closing date of November 10, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://beta.sam.gov/. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be emailed to: Matthew.Poulin@va.gov.   The estimated annual requirements are as follows:   ITEM DESCRIPTION SIZE (TABS PER BOTTLE) ESTIMATED ANNUAL REQUIREMENTS (BOTTLES) 1 BUPRENORPHINE HCL 2MG/NALOXONE HCL 0.5MG TAB,SUBLINGUAL 30 145,412 2 BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SUBLINGUAL 30 275,699

Inactive

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0001 for an unrestrictive procurement for Buprenorphine HCL/Naloxone HCL Sublingual Ta... PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0001 for an unrestrictive procurement for Buprenorphine HCL/Naloxone HCL Sublingual Tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79721R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 27, 2020, with a tentative closing date of November 10, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://beta.sam.gov/. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be emailed to: Matthew.Poulin@va.gov.   The estimated annual requirements are as follows:   ITEM DESCRIPTION SIZE (TABS PER BOTTLE) ESTIMATED ANNUAL REQUIREMENTS (BOTTLES) 1 BUPRENORPHINE HCL 2MG/NALOXONE HCL 0.5MG TAB,SUBLINGUAL 30 145,412 2 BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SUBLINGUAL 30 275,699